RRC ID 38155
著者 Watson SL, Daniels JT, Geerling G, Dart JK.
タイトル Clinical trials of therapeutic ocular surface medium for moderate to severe dry eye.
ジャーナル Cornea
Abstract PURPOSE:To investigate therapeutic ocular surface medium (TOSM), a potential physiological tear replacement therapy, for moderate to severe dry eye.
METHODS:Forty-six patients with symptoms of moderate to severe dry eye despite maximal standard therapy were enrolled in a prospective pilot study of TOSM over 1 month (n = 10) and a randomized, double-masked, controlled trial of TOSM versus saline (placebo) over 2 months (n = 36). The primary outcome measure was conjunctival rose bengal staining.
RESULTS:An improvement in conjunctival rose bengal staining by ≥3 points occurred in 7 of 10 patients receiving TOSM in the pilot study (P = 0.017) and in 8 of 18 patients (44%) in the randomized trial (P = 0.982). In the pilot study, subjective dry eye symptoms significantly improved (P = 0.005). TOSM significantly improved the blepharitis score (P = 0.002) and conjunctival impression cytology (P = 0.028) in the randomized controlled trial. There were no serious or irreversible side effects with TOSM.
CONCLUSIONS:TOSM is a physiological tear replacement for dry eye that, unlike autologous serum, can be easily manufactured, could be widely available, and may also be beneficial for blepharitis.
巻・号 29(11)
ページ 1241-6
公開日 2010-11-1
DOI 10.1097/ICO.0b013e3181d82f5e
PMID 20697273
MeSH Adult Aged Blepharitis / drug therapy Blepharitis / pathology Cell Survival / drug effects Conjunctiva / pathology Double-Blind Method Dry Eye Syndromes / drug therapy* Dry Eye Syndromes / pathology Dry Eye Syndromes / physiopathology Female Fluorescent Dyes Humans Male Middle Aged Ophthalmic Solutions / therapeutic use* Pilot Projects Prospective Studies Rose Bengal Severity of Illness Index Staining and Labeling Young Adult
IF 2.215
引用数 12
WOS 分野 OPHTHALMOLOGY
リソース情報
ヒト・動物細胞 HCE-T(RCB2280)